Impact Factor
3.62
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.99
1,195 total citations
h5-index
41
h5 depth signal
Cited share
57.1%
178 of 312
Total citations
1,195
Citation footprint
Metric signal
3.92
External metric anchor
Self-citation
0.3%
4 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,683
China
274
Canada
138
United Kingdom
129
Japan
98
Citing Fields of Research
Cancer & Development
1,059
Cancer, Autophagy & Apoptosis
765
Breast Cancer
543
Oncology
432
Cell Biology
371
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,970
Articles tracked across the journal lifetime
Indexed publication set
312
178 cited publications
Last 12 months
91
7.6 publications/month
Open access share
17.6%
16 OA publications in the last year
Leading citing country
United States
1,683 citing publications
Leading citing field
Cancer & Development
1,059 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v1n1,Nov. 2002-
v1n1,Nov. 2002-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cancer & Development
Cancer, Autophagy & Apoptosis
Immunology
Prostate Cancer
Noncoding RNA
Breast Cancer
Issuing & Sponsoring Bodies
Contributor
American Association for Cancer Research
Broad Categories
Cell Biology
Molecular Biology
Neoplasms
Cancer & Development
Cancer, Autophagy & Apoptosis
Noncoding RNA
Prostate Cancer
Digestive Disorders
MeSH Descriptors
Cells
Molecular Biology
Neoplasms
Research
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1158/1541-7786.mcr-26-0205
Open DOI
PAX3::FOXO1 and the INO80 complex sustain replication fork progression in fusion positive rhabdomyosarcoma
Transcription factor fusions are recurrent drivers of sarcomas and other cancers, but their oncogenic reorganization of chromatin is difficult to target. One such fusion, PAX3::FOXO1, drives an aggressive subset of pediatric rhabdomyosar...
02
DOI 10.1158/1541-7786.mcr-25-0982
Open DOI
Functional Characterization of Breast Cancer-Associated Histone Mutations
Cancer-related somatic histone mutants are present in 4% of diverse tumor types and display a similar genomic prevalence to other somatic mutations in cancer, but they are not well characterized. We curated and characterized 17 of the mo...
03
DOI 10.1158/1541-7786.mcr-26-0126
Open DOI
tRF-3021a Promotes Apoptosis Resistance and Global Protein Synthesis in Cancer Cell Lines
TRNA-derived fragments (tRFs) are a relatively recently discovered class of small RNAs implicated in gene-regulation, particularly behaving as microRNA to degrade target mRNAs with seed-sequence matches, but there have been very few repo...
04
DOI 10.1158/1541-7786.mcr-26-0497
Open DOI
ANAPC7 Promotes Triple-Negative Breast Cancer Progression through ANAPC2-Dependent Degradation of PCGF2 and Activation of STAT3
Although dysregulation of the E3 ubiquitin ligase anaphase-promoting complex/cyclosome (APC/C) and the signal transducer and activator of transcription 3 (STAT3) activation have been linked to tumorigenesis, it is unclear how ANAPC7 (a s...
05
DOI 10.1158/1541-7786.mcr-26-0463
Open DOI
Comparative Transcriptomic and Immune Profiling Reveals a Shared Molecular Identity between Clear Cell Odontogenic Carcinoma and Hyalinizing Clear Cell Carcinoma
Clear cell odontogenic carcinoma (CCOC) and hyalinizing clear cell carcinoma (HCCC), rare head and neck malignancies with recurrent EWSR1::CREB family fusions, show overlapping morphologic and immunophenotypic features; no standardized s...
06
DOI 10.1158/1541-7786.mcr-25-1256
Open DOI
PPP1CA drives osteosarcoma tumorigenesis by promoting PKM2 dephosphorylation and tetramerization
Osteosarcoma (OS) is a highly aggressive malignant tumor with no effective targeted therapies at present. Aerobic glycolysis represents a hallmark metabolic feature of OS, wherein the glycolytic rate-limiting enzyme pyruvate kinase M2 is...
07
DOI 10.1158/1541-7786.mcr-24-10-hi
Open DOI
Selected Articles from This Issue
08
09
DOI 10.1158/1541-7786.mcr-26-0652
Open DOI
Correction: BRAFV600E-Driven Lung Adenocarcinoma Requires Copper to Sustain Autophagic Signaling and Processing
10
DOI 10.1158/1541-7786.mcr-26-0573
Open DOI
Immunometabolic effects of oral testosterone for castration-resistant prostate cancer in the ACROBAT trial
High-dose testosterone is an emerging treatment option for selected patients with castration-resistant prostate cancer (CRPC), but its efficacy is limited by frequent primary and acquired resistance. Preclinical studies suggest that high...
Bibliographical & Catalog Notes
Title from cover.
"A journal of the molecular and cellular biology of cancer."
Print issues ceased with v. 18, no. 12 (Dec. 2020).
Issue for Nov. 2002 also called: Inaugural issue.
Vol. 1 encompasses the Nov. and Dec. 2002 issues as well as 12 issues published in 2003; beginning with v. 2 in 2004, each v. will consist of 12 issues published monthly.
Also issued online.